Related Experiment Video
Updated: May 28, 2025

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
[A Case of a Giant Rectal GIST Markedly Responsive to Neoadjuvant Chemotherapy with Imatinib Mesylate]
Masato Yamamoto1, Kenji Kato, Kasumi Hayashi
1Dept. of Surgery, Matsusaka Central General Hospital.
Abstract:
A 74-year-old man complaining of perianal pain was referred to our hospital. A contrast-enhanced computed tomography scan showed a giant mass measuring 10.3 cm between the rectum and the prostate. Magnetic resonance imaging showed contrast effect and decreased diffusion at the margins, with hemorrhage and necrosis inside the mass. We performed a transperineal needle biopsy, it was diagnosed as rectal gastrointestinal stromal tumor(GIST). Complete resection of the tumor was difficult, we started neoadjuvant chemotherapy with imatinib mesylate(400 mg/day)for reduced the diameter of the tumor. The tumor diameter(reduction rate)at 1, 3, and 5 months after treatment was 7.4 cm(28%), 7.0 cm(32%), and 6.2 cm(40%). We considered complete surgical resection possible and performed a robot-assisted rectal resection with no tumor damage. Pathological examination was consistent with a rectal GIST, and the resection margins were negative. We report a case of a giant rectal GIST markedly responsive to neoadjuvant chemotherapy with imatinib mesylate.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...